Loading...

Intracellular Staining Permeabilization Wash Buffer (10X)

Pricing & Availability
Regulatory Status
RUO
Other Names
Perm/Wash, Permeabilization Buffer
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
421002 100 mL $94
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Intracellular Staining Permeabilization Wash Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Intracellular Staining Permeabilization Wash Buffer is used to permeabilize cells following fixation with Intracellular Staining Fixation Buffer (Cat. No. 420801). It is supplied as a 10X solution and should be diluted in deionized water prior to use. Intracellular Staining Permeabilization Wash Buffer has been formulated to have minimal effects on cells, reduce non-specific staining and enhance the signal to noise ratio. It can be used for antibody dilutions and cell washing during intracellular staining.

Product Details
Technical data sheet

Product Details

Storage & Handling
The Intracellular Staining Perm wash buffer solution should be stored between 2°C and 8°C. Do not freeze.
Application

ICC, ICFC - Quality tested
IHC - Reported in the literature, not verified in house
Recommended Usage

For use in permeabilization, dilute Intracellular Staining Permeabilization Wash Buffer (10X) to 1X in DI water. Resuspend fixed cells in diluted Intracellular Staining Permeabilization Wash Buffer and centrifuge at 350 xg for 5-10 minutes, and repeat the process twice. It is recommended that the reagent be titrated for optimal performance for each application. Please see "Intracellular Cytokine Staining Protocol" on BioLegend's website for more details.

Application Notes

The Intracellular Staining Permeabilization Wash Buffer (10X) may have crystallization or precipitation observed when it is stored at 2-8°C; however, this is normal and does not affect the buffer's performance. If there is heavy precipitation observed after dilution to 1X working solution, the buffer can be filtered to clarify the solution.

Application References

(PubMed link indicates BioLegend citation)
  1. Smeltz RB. 2007. J. Immunol. 178:4786.
  2. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  3. del Rio ML, et al. 2011. Transplantation. 92:1085. PubMed
  4. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  5. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  6. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  7. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  8. Ni PP, et al. 2014. J Immunol. 193:1778. PubMed
Product Citations
  1. Arbues A, et al. 2020. PLoS Pathog. 16:e1008312. PubMed
  2. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  3. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  4. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  5. Nozaki K, et al. 2022. Nature. 606:960. PubMed
  6. Shemesh A, et al. 2022. J Exp Med. 219: . PubMed
  7. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  8. Blanas A, et al. 2022. iScience. 25:104719. PubMed
  9. Bates TA, et al. 2022. Cell Rep. 41:111544. PubMed
  10. Gong YY, et al. 2022. Cancer Res Commun. 2:842. PubMed
  11. Liang Y, et al. 2022. Theranostics. 12:7729. PubMed
  12. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  13. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  14. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  15. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  16. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  17. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  18. Chan L, et al. 2022. Cells. 12: . PubMed
  19. Ding D, et al. 2023. J Med Chem. 66:1467. PubMed
  20. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  21. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  22. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  23. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  24. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  25. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  26. Guo H, et al. 2022. Biomaterials. 283:121441. PubMed
  27. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  28. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  29. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  30. Chen R, et al. 2022. J Mol Cell Biol. 14:. PubMed
  31. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  32. Shen M, et al. 2022. Adv Sci (Weinh). 9:e2203523. PubMed
  33. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  34. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  35. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  36. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  37. Stokes JV, et al. 2022. Curr Protoc. 2:e584. PubMed
  38. Jia DJ, et al. 2022. Gut Microbes. 14:2145843. PubMed
  39. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  40. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  41. Mohamed GA, et al. 2023. Breast Cancer Res. 25:23. PubMed
  42. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  43. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  44. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  45. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  46. Changsheng H, et al. 2023. Sci Adv. 9:eade4186. PubMed
  47. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  48. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  49. Komoto S, et al. 2023. Cancers (Basel). 15:. PubMed
  50. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  51. Hanga MP, et al. 2021. Biotechnol Bioeng. 118:3175. PubMed
  52. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  53. Kim S, et al. 2020. Development. 147:00:00. PubMed
  54. Dumauthioz N, et al. 2020. Cell Mol Immunol. . PubMed
  55. Rappazzo CG, et al. 2020. bioRxiv. . PubMed
  56. Khayrullina G, et al. 2020. Skelet Muscle. 10:16. PubMed
  57. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  58. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  59. Glaser K, et al. 2015. Immunol Lett. 166: 19-27. PubMed
  60. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  61. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  62. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  63. Lebedeva IV, et al. 2021. Cell Death Dis. 12:770. PubMed
  64. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  65. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  66. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  67. Huang X, et al. 2019. Cancer Immunol Res. 1.388888889. PubMed
  68. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  69. Jacob A, et al. 2020. Nature Protocols. 14(12):3303-3332.. PubMed
  70. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  71. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  72. Poli V, et al. 2021. iScience. 24:103256. PubMed
  73. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  74. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  75. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  76. Stewart CA, et al. 2020. bioRxiv. . PubMed
  77. Stewart CA, et al. 2021. J Thorac Oncol. Online ahead of prin. PubMed
  78. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  79. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  80. Goyal S, et al. 2017. Sci Rep. . 10.1038/s41598-017-18046-x. PubMed
  81. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  82. Gärtner F, et al. 2021. Front Immunol. 12:745132. PubMed
  83. Gao F, et al. 2021. Front Cell Infect Microbiol. 10:593805. PubMed
  84. Haque M, et al. 2021. STAR Protoc. 2:100264. PubMed
  85. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  86. Ghose J, et al. 2018. Oncoimmunology. 7:e1486948. PubMed
  87. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  88. Shinde MY, et al. 2017. J Biol Chem. 292:18240. PubMed
  89. Lau H, et al. 2021. Int J Mol Sci. 22:. PubMed
  90. Zhou H, et al. 2022. J Clin Invest. 132:. PubMed
  91. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  92. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  93. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  94. Sohrabi Y, et al. 2020. Front Immunol. 11:353. PubMed
  95. Martinez–Usatorre A, et al. 2018. J Immunol. 201:792. PubMed
  96. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  97. Ni P, et al. 2014. J Immunol . 193:1778. PubMed
  98. Lau H, et al. 2021. Xenotransplantation. 28:e12667. PubMed
  99. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  100. Ma Q, et al. 2022. Nat Commun. 13:4142. PubMed
  101. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  102. Jiang P, et al. 2021. Nat Methods. 18:1181. PubMed
  103. Zhan Y, et al. 2021. JCI Insight. 6:. PubMed
  104. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  105. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  106. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  107. Clancy–Thompson E, et al. 2018. Cancer Immunol Res. 1.308333333. PubMed
  108. Xiao Z, et al. 2013. Mol Immunol. 56:423. PubMed
  109. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  110. Zhang X, et al. 2022. Theranostics. 12:1621. PubMed
  111. Berical A, et al. 2022. Nat Commun. 13:4270. PubMed
  112. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  113. Baek J, et al. 2017. Am J Pathol. 10.1016/j.ajpath.2017.02.011. PubMed
  114. Pearce V, et al. 2015. J Immunol. 195: 3206 - 3217. PubMed
  115. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  116. Rodriguez S, et al. 2020. Xenotransplantation. 27:e12554. PubMed
  117. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  118. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  119. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  120. Lownik JC, et al. 2019. J Immunol. 202:664. PubMed
  121. Mkhikian H, et al. 2022. Nat Aging. 2:231. PubMed
  122. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  123. Lau H, et al. 2020. Xenotransplantation. 27:e12555. PubMed
  124. Breznik JA, et al. 2018. Physiol Rep. 6:e13937. PubMed
  125. Ren Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  126. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  127. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  128. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  129. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  130. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  131. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  132. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  133. Ouyang W, et al. 2021. Invest Ophthalmol Vis Sci. 62:25:00. PubMed
  134. Nausch N, et al. 2017. PLoS Negl Trop Dis. 11(2):e0005415. PubMed
  135. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  136. Page N, et al. 2021. Nat Commun. 12:1009. PubMed
  137. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  138. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  139. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  140. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  141. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  142. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  143. Hayes D, et al. 2022. JCI Insight. 7:. PubMed
  144. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  145. Gong C, et al. 2021. Mol Cell. 81:4059. PubMed
  146. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  147. Kim S, et al. 2020. Development. . PubMed
  148. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  149. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  150. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  151. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  152. Ma K, et al. 2022. iScience. 25:104347. PubMed
  153. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  154. Wang G, et al. 2020. Nat Commun. 0.611111111. PubMed
  155. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  156. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  157. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  158. Haswell JR, et al. 2021. PLoS One. 16:e0252848. PubMed
  159. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  160. Lau H, et al. 2020. Islets. 41:12. PubMed
  161. Lau H, et al. 2020. PLoS One. 15:e0243506. PubMed
  162. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  163. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  164. Xia Y, et al. 2018. Cell. 175:1059. PubMed
  165. Spiliopoulou P, et al. 2022. Mol Cancer Ther. . PubMed
  166. Tintos-Hernandez JA, et al. 2021. Brain Commun. 3:fcab215. PubMed
  167. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  168. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  169. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  170. Gao J, et al. 2022. Front Immunol. 13:955812. PubMed
  171. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  172. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  173. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  174. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  175. Sun X, et al. 2017. Microbes Infect. 10.1016/j.micinf.2017.08.007. PubMed
  176. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  177. Reuschl AK, et al. 2022. Cell Rep. 39:110650. PubMed
  178. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  179. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  180. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  181. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  182. Lee G, et al. 2021. Viruses. 13: . PubMed
  183. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  184. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  185. Mcgaw C, et al. 2022. Nat Commun. 13:2833. PubMed
  186. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  187. Hernandez AA, et al. 2020. J Immunol. 205:2806. PubMed
  188. Su Y, et al. 2020. Cell. 1479:183. PubMed
  189. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  190. Giadone RM, et al. 2018. Amyloid. 25:148. PubMed
  191. Gebremeskel S, et al. 2017. Cancer Immunol Res. 0.9625. PubMed
  192. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  193. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  194. van Loon K, et al. 2022. Cancers (Basel). 14:. PubMed
  195. Wang X, et al. 2022. Elife. 11:. PubMed
  196. Liu X, et al. 2021. Adv Sci (Weinh). 8:e2100233. PubMed
  197. Heckler M, et al. 2021. Cancer Discov. Online ahead of prin. PubMed
  198. Zheng L, et al. 2020. Clin Cancer Res. 26:3694. PubMed
  199. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  200. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  201. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  202. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  203. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  204. Assadi G, et al. 2016. PLoS One. 11:e0168276. PubMed
  205. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  206. Lei F, et al. 2012. J Vis Exp. 63: 3986. PubMed
  207. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  208. Luvanda MK, et al. 2021. J Fungi (Basel). 7:. PubMed
  209. Chen S, et al. 2020. Cancer Immunol Res. 1064:8. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA

Related FAQs

There are no FAQs for this product.
Go To Top Version: 3    Revision Date: 08/26/2015

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login/Register
Remember me
Forgot your password? Reset Password
Request an Account